The Office of the Assistant Secretary for Planning and Evaluation (ASPE) has released a planning document setting out how the federal government will rewrite the National Plan to Address Alzheimer's Disease to cover 2026 through 2035, moving the effort from internal deliberation to a public process. The document, published around August 1, 2026, lays out mechanics that have not previously been made public in this form: a formal request for information inviting written comment from researchers, clinicians, caregivers and the public, review of that input by the statutory Advisory Council on Alzheimer's Research, Care, and Services, and a target release date in late 2026 for the finished plan. HHS confirmed the update through a Federal Register notice opening a comment docket (HHS-ASPE-2026-0298) on July 24, 2026, seeking input on gaps and opportunities across research, care, and services for Alzheimer's disease and related dementias. The Advisory Council itself discussed a plan for the 2026-2035 update at a public meeting in January 2026, according to a separate Federal Register notice, indicating the process had been under internal discussion for months before the RFI and ASPE approach document made it public. The National Plan, first issued in 2012 under the National Alzheimer's Project Act and updated periodically since, functions as the government's roadmap for coordinating federal research funding, caregiver support programs and public health surveillance across agencies including the National Institutes of Health, the Centers for Disease Control and Prevention, and the Department of Veterans Affairs; it does not itself fund research or approve treatments. Advocacy and research organizations have already begun submitting formal comments to the docket, with at least one nonprofit research group urging HHS to prioritize research that directly informs patient care and to require federal agencies to analyze and publicly release existing registry data on dementia care outcomes.